RNA-binding proteins in human genetic disease
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“For example, epidermal growth factor receptor 2 (HER2) gene amplification is frequently observed in breast cancer [ 64 ], and activating mutations in the RAS oncogene are highly prevalent in colon cancer [65].”
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Dicer is essential for mouse development
Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., Mills, A. A., Elledge, S. J., Anderson, K. V., & Hannon, G. J. (2003) · Nature Genetics · doi:10.1038/ng1253 · Cited by 1,627
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583 · cited 1×
“For example, epidermal growth factor receptor 2 (HER2) gene amplification is frequently observed in breast cancer [64], and activating mutations in the RAS oncogene are highly prevalent in colon cancer [ 65 ].”
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R., & Jacks, T. (2007) · Nature Genetics · doi:10.1038/ng2003 · Cited by 1,463
Selective Blockade of MicroRNA Processing by Lin28
Viswanathan, S. R., Daley, G. Q., & Gregory, R. I. (2008) · Science · doi:10.1126/science.1154040 · Cited by 1,437
RNA‐binding proteins and post‐transcriptional gene regulation
Glisovic, T., Bachorik, J. L., Yong, J., & Dreyfuss, G. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.004 · Cited by 1,398
RNA regulons: coordination of post-transcriptional events
Keene, J. D. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2111 · Cited by 1,321
Cited by
Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
Castello, A., Fischer, B., Eichelbaum, K., Horos, R., Beckmann, B. M., Strein, C., Davey, N. E., Humphreys, D. T., Preiss, T., Steinmetz, L. M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.031 · Cited by 2,132
“Against this background, it is unsurprising that numerous diseases have been linked to defects in RBP expression and function, including neuropathies, muscular atrophies, metabolic disorders, and cancer (Cooper et al., 2009; Darnell, 2010; Lukong et al., 2008).”
A census of human RNA-binding proteins
Gerstberger, S., Hafner, M., & Tuschl, T. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3813 · Cited by 2,032
A large-scale binding and functional map of human RNA-binding proteins
Van Nostrand, E. L., Freese, P., Pratt, G. A., Wang, X., Wei, X., Xiao, R., Blue, S. M., Chen, J.-Y., Cody, N. A. L., Dominguez, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2077-3 · Cited by 1,317
Cooper, T. A., Wan, L., & Dreyfuss, G. (2009) · Cell · doi:10.1016/j.cell.2009.02.011 · Cited by 1,159
Role of Stress Granules and RNA-Binding Proteins in Neurodegeneration: A Mini-Review
Vanderweyde, T., Youmans, K., Liu-Yesucevitz, L., & Wolozin, B. (2013) · Gerontology · doi:10.1159/000354170 · Cited by 805
RNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 773
Revealing protein–lncRNA interaction
Ferrè, F., Colantoni, A., & Helmer-Citterich, M. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv031 · Cited by 702
Comprehensive Identification of RNA-Binding Domains in Human Cells
Castello, A., Fischer, B., Frese, C. K., Horos, R., Alleaume, A.-M., Foehr, S., Curk, T., Krijgsveld, J., & Hentze, M. W. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.029 · Cited by 637
MicroRNA regulation by RNA-binding proteins and its implications for cancer
van Kouwenhove, M., Kedde, M., & Agami, R. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3107 · Cited by 617
“More than 500 human RBPs are known, but only a few have been assigned an oncogenic or tumour-suppressive function (reviewed in Ref”
BackgroundRBM20, a gene for hereditary cardiomyopathy, regulates titin splicing
Guo, W., Schafer, S., Greaser, M. L., Radke, M. H., Liss, M., Govindarajan, T., Maatz, H., Schulz, H., Li, S., Parrish, A. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2693 · Cited by 589
Posttranscriptional regulation of cancer traits by HuR
Abdelmohsen, K., & Gorospe, M. (2010) · WIREs RNA · doi:10.1002/wrna.4 · Cited by 412
Dewey, C. M., Cenik, B., Sephton, C. F., Dries, D. R., Mayer, P., Good, S. K., Johnson, B. A., Herz, J., & Yu, G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01279-10 · Cited by 366
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
Wang, E., Lu, S. X., Pastore, A., Chen, X., Imig, J., Chun-Wei Lee, S., Hockemeyer, K., Ghebrechristos, Y. E., Yoshimi, A., Inoue, D., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.010 · Cited by 338
“Considering that RBPs are key regulators of gene expression, alterations of these proteins are also implicated in several human genetic diseases, including multiple cancers (Cooper et al., 2009; Kapeli et al., 2017; Lukong et al., 2008).”
BackgroundSite identification in high-throughput RNA–protein interaction data
Uren, P. J., Bahrami-Samani, E., Burns, S. C., Qiao, M., Karginov, F. V., Hodges, E., Hannon, G. J., Sanford, J. R., Penalva, L. O. F., & Smith, A. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts569 · Cited by 323
LIN28 Binds Messenger RNAs at GGAGA Motifs and Regulates Splicing Factor Abundance
Wilbert, M. L., Huelga, S. C., Kapeli, K., Stark, T. J., Liang, T. Y., Chen, S. X., Yan, B. Y., Nathanson, J. L., Hutt, K. R., Lovci, M. T., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.004 · Cited by 267
Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA
Brown, J. A., Kinzig, C. G., DeGregorio, S. J., & Steitz, J. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614759113 · Cited by 260
Cytoplasmic Rbfox1 Regulates the Expression of Synaptic and Autism-Related Genes
Lee, J.-A., Damianov, A., Lin, C.-H., Fontes, M., Parikshak, N. N., Anderson, E. S., Geschwind, D. H., Black, D. L., & Martin, K. C. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.025 · Cited by 232
“Mutations in RBPs have been found to cause and/or contribute to many human neurodevelopmental and neurologic disorders (Darnell and Richter, 2012; Lukong et al., 2008).”
BackgroundCompetition between target sites of regulators shapes post-transcriptional gene regulation
Jens, M., & Rajewsky, N. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3853 · Cited by 258
RNA-binding proteins in Mendelian disease
Castello, A., Fischer, B., Hentze, M. W., & Preiss, T. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.01.004 · Cited by 255
Kazan, H., Ray, D., Chan, E. T., Hughes, T. R., & Morris, Q. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000832 · Cited by 255
Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers
Wang, Z.-L., Li, B., Luo, Y.-X., Lin, Q., Liu, S.-R., Zhang, X.-Q., Zhou, H., Yang, J.-H., & Qu, L.-H. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.035 · Cited by 204
Conserved mRNA-binding proteomes in eukaryotic organisms
Matia-González, A. M., Laing, E. E., & Gerber, A. P. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3128 · Cited by 191
“765 1 2 3 1 2 3 (1) n = 496 (2) n = 836”
Nova2 Regulates Neuronal Migration through an RNA Switch in Disabled-1 Signaling
Yano, M., Hayakawa-Yano, Y., Mele, A., & Darnell, R. B. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.007 · Cited by 176
Classification, diagnosis and potential mechanisms in Pontocerebellar Hypoplasia
Namavar, Y., Barth, P. G., Poll-The, B. T., & Baas, F. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-50 · Cited by 175
“The identification of mutations in genes involved in transcription and translation in neurological disorders shows that these processes are important in (developing) neurons [83,89-94].”
BackgroundSwindell, W. R. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-585 · Cited by 171
“This effect of CR may be consequential for disease processes, since proteins that regulate splicing events can contribute to cell growth and the proliferation of cancer cells [64-66].”
BackgroundYagi, M., Uchiumi, T., Takazaki, S., Okuno, B., Nomura, M., Yoshida, S.-I., Kanki, T., & Kang, D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks774 · Cited by 169
De Rubeis, S., & Bagni, C. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.09.013 · Cited by 126
“…alterations in their functions can profoundly affect n (VIB11), Belgium & Univer- .bagni@cme.vib-kuleuven.be ll rights reserved. the control of gene expression and lead to a broad spectrum of human diseases that are due to both loss-of- and gain-of-function mutations (Lukong et al., 2008).”
Bronicki, L. M., & Jasmin, B. J. (2013) · RNA · doi:10.1261/rna.039164.113 · Cited by 126
Wagnon, J. L., Briese, M., Sun, W., Mahaffey, C. L., Curk, T., Rot, G., Ule, J., & Frankel, W. N. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003067 · Cited by 125
“RNA-binding proteins (RBPs) are increasingly being associated with complex genetic diseases, as they can regulate the expression of many genes co-transcriptionally or post-transcriptionally via interactions with mRNA [14,15,16].”
BackgroundRNA-binding proteins in neurodegeneration: Seq and you shall receive
Nussbacher, J. K., Batra, R., Lagier-Tourenne, C., & Yeo, G. W. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.02.003 · Cited by 115
Mittal, N., Roy, N., Babu, M. M., & Janga, S. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906940106 · Cited by 103
“In particular, disorders such as myotonic dystrophy (DM) and oculopharyngeal muscular dystrophy (OPMD) have been attributed to RNA’s gain-of-function by CUG repeat expansion in the case of myotonic dystrophy protein kinase (DMPK) (19) and GCG repeat expansion in exon 1 of the RBP, PABPN1 in the case of OPMD (7), respe…”
BackgroundResultInfluentialThe ribonome: a dominant force in co‐ordinating gene expression
Mansfield, K. D., & Keene, J. D. (2009) · Biology of the Cell · doi:10.1042/bc20080055 · Cited by 102
“…multiple mRNAs change together in a co-ordinated fashion following cell perturbations, whether internally or externally derived (Lam et al., 2001; Wang, Y. et al., 2002; Yang et al., 2003; Grigull et al., 2004; Raghavan et al., 2004; Cammas et al., 2008; Lukong et al., 2008; DeGracia et al., 2008).”
BackgroundSeyfried, N. T., Gozal, Y. M., Donovan, L. E., Herskowitz, J. H., Dammer, E. B., Xia, Q., Ku, L., Chang, J., Duong, D. M., Rees, H. D., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr2010814 · Cited by 64
“RNA-binding proteins interact with coding, untranslated and non–protein-coding RNAs in functional units called ribonucleoprotein (RNP) complexes [63, 64].”
BackgroundThe Architecture of the Human RNA-Binding Protein Regulatory Network
Quattrone, A., & Dassi, E. (2019) · iScience · doi:10.1016/j.isci.2019.10.058 · Cited by 53
Jin, W., Brannan, K. W., Kapeli, K., Park, S. S., Tan, H. Q., Gosztyla, M. L., Mujumdar, M., Ahdout, J., Henroid, B., Rothamel, K., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.019 · Cited by 52
Nithin, C., Ghosh, P., & Bujnicki, J. M. (2018) · Genes · doi:10.3390/genes9090432 · Cited by 48
“Defects in RNP interactions are implicated in many diseases ranging from neurological disorders to cancer [14,15].”
BackgroundAberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice
Sun, W., Wagnon, J. L., Mahaffey, C. L., Briese, M., Ule, J., & Frankel, W. N. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.240168 · Cited by 36
“Dysregulation of RBPs can therefore affect the expression of many genes, often leading to disease (Lukong et al. 2008).”
BackgroundRNA–Binding Protein HuD as a Versatile Factor in Neuronal and Non–Neuronal Systems
Jung, M., & Lee, E. K. (2021) · Biology · doi:10.3390/biology10050361 · Cited by 39
“Therefore, approaches that restore the abundance or function of RBPs have great potential for clinical applications [10,117].”
BackgroundLee, J., Villarreal, O. D., Chen, X., Zandee, S., Young, Y. K., Torok, C., Lamarche-Vane, N., Prat, A., Rivest, S., Gosselin, D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108560 · Cited by 38
Self-citationThe RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis
Coleman, J. C., Tattersall, L., Yianni, V., Knight, L., Yu, H., Hallett, S. R., Johnson, P., Caetano, A. J., Cosstick, C., Ridley, A. J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109288 · Cited by 15
The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis
Coleman, J. C., Tattersall, L., Yianni, V., Knight, L., Yu, H., Hallett, S., Johnson, P., Caetano, A., Cosstick, C., Ridley, A., et al. (2023) · doi:10.1101/2023.04.11.536377 · Cited by 15
(2025) · doi:10.1016/j.cels.2025.101400 · Cited by 4
Metadata
- Authors
- Lukong, K. E., Chang, K.-W., Khandjian, E. W., & Richard, S.
- Venue
- Trends in Genetics
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 24
- Issue
- 8
- Pages
- 416-425
- ISSN
- 0168-9525 (ISSN-L)
- OpenAlex
- W2076563297
- Cited by
- 646
- References
- 95
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.